Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2002 1
2004 1
2008 1
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Refractory EBV-Related Lymphoma"
Page 1
Safety of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for patients with refractory EBV-related lymphoma.
Sun Q, Burton R, Reddy V, Lucas KG. Sun Q, et al. Br J Haematol. 2002 Sep;118(3):799-808. doi: 10.1046/j.1365-2141.2002.03683.x. Br J Haematol. 2002. PMID: 12181048 Free article. Clinical Trial.
In this pilot study, we have treated four patients with EBV-related lymphoma using allogeneic EBV-specific CTL. Two patients received EBV-specific CTL derived from partially human leucocyte antigen (HLA)-matched donors and the other two from HLA-matched sibli …
In this pilot study, we have treated four patients with EBV-related lymphoma using allogeneic EBV-specific CTL. Two pat …
Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T, Piche A, Kasono K, Xiang J, Gomez-Navarro J, Moriuchi S, Krisky DM, Oligino T, Glorioso JC, Curiel TJ, Curiel DT. Suzuki T, et al. Biochem Biophys Res Commun. 1998 Nov 27;252(3):686-90. doi: 10.1006/bbrc.1998.9685. Biochem Biophys Res Commun. 1998. PMID: 9837767
We used the lymphoblastoid cell line SWEIG as a model for human EBV-related B cell malignancy. This cell line was established by in vitro EBV infection of primary human peripheral blood mononuclear cells. ...These results suggest the potential utility of replication …
We used the lymphoblastoid cell line SWEIG as a model for human EBV-related B cell malignancy. This cell line was established …
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease.
Piñana JL, Sanz J, Esquirol A, Martino R, Picardi A, Barba P, Parody R, Gayoso J, Montesinos P, Guidi S, Terol MJ, Moscardó F, Solano C, Arcese W, Sanz MA, Sierra J, Sanz G; GETH GITMO groups. Piñana JL, et al. Eur J Haematol. 2016 Feb;96(2):128-35. doi: 10.1111/ejh.12557. Epub 2015 Apr 18. Eur J Haematol. 2016. PMID: 25845981 Clinical Trial.
The non-relapse mortality (NRM) at 100 d and 4 yr was 30% (95% C.I., 13-46%) and 47% (95% C.I., 29-65%), respectively. EBV-related post-transplant lymphoproliferative disease (EBV-PTLD) accounted for more than one-third of transplant-related death, with an estimate …
The non-relapse mortality (NRM) at 100 d and 4 yr was 30% (95% C.I., 13-46%) and 47% (95% C.I., 29-65%), respectively. EBV-related …
Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes.
Emanuel DJ, Lucas KG, Mallory GB Jr, Edwards-Brown MK, Pollok KE, Conrad PD, Robertson KA, Smith FO. Emanuel DJ, et al. Transplantation. 1997 Jun 15;63(11):1691-4. doi: 10.1097/00007890-199706150-00027. Transplantation. 1997. PMID: 9197369
The patient received three separate mononuclear cell infusions over a 9-month period, each containing 1 x 10(6) CD3+ mononuclear cells per kilogram. Complete clinical, radiological, and pathological remission was achieved with this treatment regimen. ...Use of allogeneic H …
The patient received three separate mononuclear cell infusions over a 9-month period, each containing 1 x 10(6) CD3+ mononuclear cells per k …
Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
Williams KM, Higman MA, Chen AR, Schwartz CL, Wharam M, Colombani P, Arceci RJ. Williams KM, et al. Pediatr Blood Cancer. 2008 Mar;50(3):667-70. doi: 10.1002/pbc.21171. Pediatr Blood Cancer. 2008. PMID: 17318876
We report a novel regimen for refractory post-transplant T-cell lymphoma (PTL). Our patient presented with non-Epstein-Barr virus (EBV) related, T-cell post-transplant lymphoproliferative disease (PTLD) 3.5 years after liver transplantation. Initially …
We report a novel regimen for refractory post-transplant T-cell lymphoma (PTL). Our patient presented with non-Epstein-Barr vi …
Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Uehara T, Nakaseko C, Hara S, Harima A, Ejiri M, Yokota A, Saito Y, Nishimura M. Uehara T, et al. Am J Hematol. 2004 Aug;76(4):368-72. doi: 10.1002/ajh.20121. Am J Hematol. 2004. PMID: 15282671 Free article.
Chronic active Epstein-Barr virus infection (CAEBV) is a heterogeneous EBV-related disorder, ranging from mild/moderate forms to rapidly lethal disorders. ...A 17-year-old female with CAEBV, who was refractory to conventional therapies and considered to be un …
Chronic active Epstein-Barr virus infection (CAEBV) is a heterogeneous EBV-related disorder, ranging from mild/moderate forms …